98%
921
2 minutes
20
Objectives: Gram-negative bacteria cause a significant proportion of neonatal late-onset sepsis (LOS) and are associated with high mortality. Emerging evidence implicates the gut as a reservoir for invasive pathogens; however, the mechanisms of gut-to-blood translocation and the role of virulence factors remain unclear.
Methods: We conducted a secondary analysis of microbiological samples from the NeoMero-1 trial, a multicentre study of neonatal LOS. Whole-genome sequencing was performed on paired blood and faecal Enterobacterales isolates from 22 neonates with gram-negative bacteria bloodstream infection and concurrent gut samples. Genetic relatedness was assessed using multilocus sequence typing and species-specific single-nucleotide polymorphism thresholds. Virulence gene profiles were characterized using the virulence factor database.
Results: In 18 of 22 cases (82%), blood and gut isolates were genetically highly related, supporting gut-to-blood translocation. All invasive Escherichia coli (7 over 7) strains consistently harboured haemolysin genes (hlyA-D), absent in all the noninvasive strains (2/2 p 0.028). Extremely preterm and low birth weight neonates were overrepresented among those with translocation.
Conclusions: Our findings support the role of gut-derived Enterobacterales in the pathogenesis of neonatal LOS. These insights may inform infection control and targeted preventive strategies. Further prospective studies are needed to validate these findings and guide interventions for high-risk neonates.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmi.2025.07.025 | DOI Listing |
Eur J Pediatr
September 2025
Pediatrics Department, Faculty of Medicine, Gharbia Governorate, El Bahr St., Tanta Qism 2, Tanta, 31527, Egypt.
Purpose: Ventilator-associated pneumonia (VAP) is a severe complication in NICUs. It increases morbidity, mortality, and healthcare costs. The research purpose was to evaluate the preventive value of probiotics on the incidence of VAP among ventilated neonates.
View Article and Find Full Text PDFEur J Pediatr
September 2025
Pediatric Surgery Department, Fattouma Bourguiba University Hospital, Monastir, Tunisia.
Unlabelled: Late-onset neonatal sepsis (LONS) remains a leading cause of morbidity and mortality in neonates, particularly among preterm and low birth weight infants. Interleukin-6 (IL-6) has emerged as a promising biomarker for early detection of LONS, yet the diagnostic performance of IL-6 remains inconsistent across studies. This meta-analysis aimed to evaluate the overall diagnostic accuracy of IL-6 in detecting LONS and to assess the certainty of evidence using the GRADE approach.
View Article and Find Full Text PDFAnn Clin Microbiol Antimicrob
August 2025
Breastfeeding Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Background: Neonatal sepsis is a major cause of morbidity and mortality worldwide. The COVID-19 pandemic has influenced its epidemiology, altering pathogen distribution and antimicrobial resistance patterns, necessitating a reassessment of neonatal infection management. This study aims to evaluate the impact of the COVID-19 pandemic on neonatal sepsis incidence, pathogen distribution, and antimicrobial resistance patterns, providing evidence to inform improved clinical management strategies in neonatal intensive care units.
View Article and Find Full Text PDFMalays J Pathol
August 2025
Tengku Ampuan Rahimah Hospital, Department of Paediatrics, Ministry of Health, Klang, Selangor, Malaysia.
Introduction: To investigate the major causes of neonatal deaths in Malaysian neonatal intensive care units (NICUs).
Materials And Methods: This retrospective observational study analysed prospectively collected data of neonates (gestation ≥22 weeks, birthweight ≥500g) admitted to 44 NICUs in the years 2015-2020 in the Malaysian National Neonatal Registry. Causes of death were reported using the modified Wigglesworth classification.
Late-onset sepsis is an important cause of mortality and morbidity in neonates. Gram-positive organisms are increasingly being recognized as causing clinically significant sepsis. was first reported as a novel species of the genus and has not been reported to cause clinically significant infections in humans.
View Article and Find Full Text PDF